Healius Ltd - Asset Resilience Ratio

Latest as of December 2015: 0.06%

Healius Ltd (HLS) has an Asset Resilience Ratio of 0.06% as of December 2015. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Healius Ltd (HLS) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

AU$2.43 Million

≈ $1.72 Million USD Cash + Short-term Investments

Total Assets

AU$3.91 Billion

≈ $2.77 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2017)

This chart shows how Healius Ltd's Asset Resilience Ratio has changed over time. See HLS book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Healius Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Healius Ltd (HLS) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$2.43 Million	0.06%
Total Liquid Assets	AU$2.43 Million	0.06%

Asset Resilience Insights

Limited Liquidity: Healius Ltd maintains only 0.06% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Healius Ltd Industry Peers by Asset Resilience Ratio

Compare Healius Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Dr. Lal Path Labs Ltd. NSE:LALPATHLAB	Diagnostics & Research	13.43%
Guangzhou Kingmed Diagnostics Group Co Ltd SHG:603882	Diagnostics & Research	0.14%
RHYTHM Biosciences Ltd AU:RHY	Diagnostics & Research	2.74%
Check-Cap Ltd. NASDAQ:MBAI	Diagnostics & Research	2.90%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Healius Ltd (2002–2017)

The table below shows the annual Asset Resilience Ratio data for Healius Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2017-06-30	0.00%	AU$0.00 ≈ $0.00	AU$3.11 Billion ≈ $2.20 Billion	--
2016-06-30	0.00%	AU$0.00 ≈ $0.00	AU$3.62 Billion ≈ $2.56 Billion	--
2015-06-30	0.08%	AU$3.20 Million ≈ $2.26 Million	AU$3.92 Billion ≈ $2.77 Billion	-0.04pp
2012-06-30	0.12%	AU$4.57 Million ≈ $3.24 Million	AU$3.86 Billion ≈ $2.73 Billion	+0.10pp
2011-06-30	0.02%	AU$798.00K ≈ $564.64K	AU$3.83 Billion ≈ $2.71 Billion	-0.02pp
2010-06-30	0.04%	AU$1.50 Million ≈ $1.06 Million	AU$3.70 Billion ≈ $2.62 Billion	-0.14pp
2009-06-30	0.18%	AU$6.93 Million ≈ $4.91 Million	AU$3.78 Billion ≈ $2.67 Billion	+0.18pp
2008-06-30	0.00%	AU$115.00K ≈ $81.37K	AU$4.80 Billion ≈ $3.40 Billion	-0.02pp
2007-06-30	0.02%	AU$135.00K ≈ $95.52K	AU$606.50 Million ≈ $429.14 Million	+0.02pp
2002-06-30	0.00%	AU$-6.00K ≈ $-4.25K	AU$283.35 Million ≈ $200.49 Million	--

pp = percentage points

About Healius Ltd

AU:HLS Australia Diagnostics & Research

Market Cap

$179.83 Million

AU$254.15 Million AUD

Market Cap Rank

#17068 Global

#490 in Australia

Share Price

AU$0.35

Change (1 day)

+0.00%

52-Week Range

AU$0.35 - AU$1.04

All Time High

AU$4.91